WCN26-6495 COMPARATIVE EFFECTIVENESS OF mRNA-1273 and BNT162b2 BOOSTER VACCINATION IN HEMODIALYSIS PATIENTS DURING THE OMICRON ERA

Read full text Summarise with VIRAT
Authors: Young‐Ki Lee, Ajin Cho, Yu Bin Seo, Hayne Cho Park, Do Hyoung Kim, Kyung Don Yoo, Jong-Woo Yoon
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Previous studies examining COVID-19 vaccine efficacy in hemodialysis patients primarily focused on the Alpha and Delta variants, reporting substantial protection after two-dose mRNA vaccination. However, evidence on the effectiveness of booster vaccination during the Omicron-dominant period remains limited. This study assessed the effectiveness of a third mRNA vaccine dose during the Omicron period, comparing protection against infection, hospitalization, and mortality between vaccine types.

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research Vaccine Coverage and Hesitancy COVID-19 Clinical Research Studies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104565–104565
Publication date
25 March 2026
Language
EN